This early-stage study tests a drug called NCS-01 in 16 people who recently had a stroke. The main goal is to see if the drug is safe and tolerable when given through an artery in the neck within 48 hours of stroke onset. Researchers will monitor side effects and changes in neuro…
Phase: PHASE1, PHASE2 • Sponsor: NC Medial Research Inc • Aim: Symptom relief
Last updated May 14, 2026 12:07 UTC